595 related articles for article (PubMed ID: 15031461)
1. Drug discovery.
Kennedy D
Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
[No Abstract] [Full Text] [Related]
2. Surviving the blockbuster syndrome.
Service RF
Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
[No Abstract] [Full Text] [Related]
3. Molecular medicine. NIH dives into drug discovery.
Couzin J
Science; 2003 Oct; 302(5643):218-21. PubMed ID: 14551416
[No Abstract] [Full Text] [Related]
4. Costing drug development.
Nat Rev Drug Discov; 2003 Apr; 2(4):247. PubMed ID: 12680358
[No Abstract] [Full Text] [Related]
5. A prescription for better prescriptions.
Woosley RL
Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
[No Abstract] [Full Text] [Related]
6. Research, regulation and development of new pharmaceuticals: past, present and future. II.
Lasagna L
Am J Med Sci; 1972 Feb; 263(2):66-78. PubMed ID: 5017858
[No Abstract] [Full Text] [Related]
7. Sending pharma better signals.
Avorn J
Science; 2005 Jul; 309(5735):669. PubMed ID: 16051753
[No Abstract] [Full Text] [Related]
8. Drug pricing. NIH report knocks tax on blockbusters.
Kaiser J
Science; 2001 Aug; 293(5535):1575. PubMed ID: 11533456
[No Abstract] [Full Text] [Related]
9. Pharmaceutical research: cost savings through innovation.
Cohen KR; Levy RA
AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463
[No Abstract] [Full Text] [Related]
10. Development of orphan products.
FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406
[No Abstract] [Full Text] [Related]
11. Hit and Lead identification: efficient practices for drug discovery.
Goodnow RA; Gillespie P
Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
[No Abstract] [Full Text] [Related]
12. A testing approach based on tiny doses still awaits big results.
Coombs A
Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
[No Abstract] [Full Text] [Related]
13. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
[TBL] [Abstract][Full Text] [Related]
14. [Research projects of pharmaceutical companies].
Okuyama S
Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):77-8. PubMed ID: 18792463
[No Abstract] [Full Text] [Related]
15. A new era of hope for the world's most neglected diseases.
The
PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
[TBL] [Abstract][Full Text] [Related]
16. Obstacles and opportunities in new drug development.
Kaitin KI
Clin Pharmacol Ther; 2008 Feb; 83(2):210-2. PubMed ID: 18202685
[No Abstract] [Full Text] [Related]
17. A gift to pharma?
Nat Med; 2005 Jul; 11(7):693. PubMed ID: 16015340
[No Abstract] [Full Text] [Related]
18. Rising costs hold up drug discovery.
Miller HI
Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
[No Abstract] [Full Text] [Related]
19. Realizing two-tiered innovation policy through drug regulation.
Ridgway WE
Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
[No Abstract] [Full Text] [Related]
20. Key factors in the rising cost of new drug discovery and development.
Dickson M; Gagnon JP
Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
